thiazoles has been researched along with azd5438 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aarts, M; Ashworth, A; Bardelli, A; Brough, R; Campbell, J; Costa-Cabral, S; Konde, A; Lord, CJ; Marinari, E; Riffell, J; Torrance, C | 1 |
1 other study(ies) available for thiazoles and azd5438
Article | Year |
---|---|
CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
Topics: Animals; Antineoplastic Agents; CDC2 Protein Kinase; Cell Line, Tumor; Colorectal Neoplasms; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Genes, Lethal; High-Throughput Screening Assays; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyrimidines; Quinolines; RNA, Small Interfering; Signal Transduction; Survival Analysis; Thiazoles; Xenograft Model Antitumor Assays | 2016 |